Ubs Asset Management Americas Inc Ocular Therapeutix, Inc Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 316,276 shares of OCUL stock, worth $3.47 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
316,276
Previous 212,952
48.52%
Holding current value
$3.47 Million
Previous $1.56 Million
88.14%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding OCUL
# of Institutions
203Shares Held
137MCall Options Held
743KPut Options Held
321K-
Deep Track Capital, LP Greenwich, CT14.3MShares$157 Million4.71% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$152 Million98.75% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$140 Million23.46% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$126 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.39MShares$92.1 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $844M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...